Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Multimodal Risk Assessment and Prevention System for Adenovirus Pneumonia in Children
ChiCTR2600117352Phase 4Not yet recruiting
- Sponsor
- Children's Hospital, Zhejiang University School of Medicine
- Start
- Jan 2026
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label trial of methylprednisolone and immune globulin in Adenovirus Pneumonia (4 arms), sponsored by Children's Hospital, Zhejiang University School of Medicine. Primary endpoints: days of fever and adverse drug reaction. Planned start Jan 2026; status: not yet recruiting.
02
Drugs
methylprednisoloneimmune globulin
03
Conditions
Adenovirus Pneumonia
Beyond the preview
Go deeper on ChiCTR2600117352.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600117352.